20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21060L | NPC 567 acetate | NPC 567 acetate(109333-26-8 Free base) | Bradykinin Receptor |
NPC 567 acetate is a bradykinin B2 antagonist and can be used in studies about the treatment of allergic airway disease. | |||
T8638 | NPC 15199 | FMOC-L-Leucine | Others |
NPC 15199 (FMOC-L-Leucine) is an anti-inflammatory agent. | |||
T33729 | Npc 573 | Npc-573,Npc573 | |
Npc 573 is a bioactive chemical. | |||
T77407 | Ensituximab | NPC-1C,NEO-102,NEO-101 | |
Ensituximab (NEO-102) is a quasi-selective IgG1 monoclonal antibody against the MUC5AC variant with anti-tumour activity that inhibits colorectal and pancreatic cancer. | |||
T70187 | NPC-18915 | ||
NPC-18915 is a benzofuran compound, inhibitor of neutophil activation. | |||
T37480 | NPC-15437 (hydrochloride) | ||
NPC-15437 (hydrochloride) is a scleclive inhibitor of PKC interacling at the regulatory domain of the enzyme。 | |||
T21060 | NPC 567 | ||
NPC 567 is an antagonist of the bradykinin receptor. | |||
T71024 | NPC-16731 | ||
NPC-16731 is a Bradykinin antagonist. | |||
T71323 | Npc 12626 | ||
Npc 12626 is a N-methyl-D-aspartate receptor antagonist; NPC 17742, the (2R,4R,5S)-isomer, is the most potent isomer in the mixture NPC 12626. | |||
T18105 | M-PEG-NPC (MW 20000) | Others | |
m-PEG-NPC (MW 20000) is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome sys... | |||
T70576 | NPC 17731 | ||
NPC 17731 is a bradykinin receptor antagonist. | |||
T70574 | NPC 17761 | ||
NPC 17761 is a bradykinin receptor antagonist. | |||
T70590 | NPC-14695 | ||
NPC-14695 is a smooth muscle-selective muscarinic antagonist with bronchodilating activity. | |||
T19553 | RPR132595A | NPC | Others |
RPR132595A is an active CPT-11 metabolite, it is generated by cytochrome P-450 3A4 (CYP3A4). | |||
T78069 | RPR132595A hydrochloride | NPC hydrochloride | Drug Metabolite |
RPR132595A (NPC) hydrochloride, an active metabolite of CPT-11, is produced via cytochrome P-450 3A4 (CYP3A4) metabolism and is ultimately eliminated via urinary excretion [1]. | |||
T71321 | (S)-VU0637120 | Others | |
(S)-VU0637120 is a selective neuropeptide Y(4)R-mutant antagonist used in the study of metabolic disorders. | |||
T70588 | Tazemetostat HCl | ||
Tazemetostat HCl is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. EPZ-6438 induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells. Treatment of... | |||
T70186 | Methazolamide-d6 | ||
Methazolamide-d6 is intended for use as an internal standard for the quantification of methazolamide by GC- or LC-MS. Methazolamide is a carbonic anhydrase inhibitor. It reduces intraocular pressure and cerebrospinal flu... | |||
T70572 | CHF-2060 | ||
CHF-2060 is a novel acetylcholinesterase inhibitor. | |||
T71023 | MI-888 free base | ||
MI-888 is a potent MDM2 inhibitor (Ki = 0.44 nM) with a superior pharmacokinetic profile and enhanced in vivo efficacy. MI-888 is capable of achieving rapid, complete, and durable tumor regression in two types of xenogra... |